Skip to main content

Table 1 Prevalence (median, range) of comorbidities based on CCDWH in GMA residents, years 2011–2017

From: Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-old

Risk factor

Age-group (years)

50–54

55–59

60–64

65–69

70–74

75–79

80–84

> 85

Total ≥ 50

Transplant

0.18 (0.17–0.18)

0.21 (0.18–0.26)

0.25 (0.20–0.32)

0.27 (0.14–0.35)

0.31 (0.21–0.38)

0.30 (0.16–0.44)

0.27 (0.08–0.46)

0.16 (0.07–0.24)

0.24 (0.16–0.32)

Renal failure

0.31 (0.29–0.38)

0.46 (0.41–0.53)

0.69 (0.58–0.84)

1.23 (0.97–1.40)

1.77 (1.48–2.19)

2.89 (2.25–3.25)

4.11 (3.30–5.03)

5.91 (4.32–7.23)

1.92 (1.17–2.32)

HIV/AIDS

0.78 (0.53–1.01)

0.50 (0.37–0.76)

0.36 (0.20–0.56)

0.23 (0.18–0.38)

0.23 (0.12–0.26)

0.10 (0.08–0.24)

0.06 (0.03–0.09)

0.02 (0.01–0.05)

0.32 (0.21–0.46)

Cancer

5.55 (4.97–6.23)

7.57 (7.24–8.23)

10.75 (9.73–11.23)

14.05 (13.38–15.18)

17.82 (15.68–19.43)

19.13 (16.76–22.75)

19.68 (17.11–22.75)

16.21 (13.18–20.5)

13.28 (11.84–14.87)

Diabetes

2.82 (2.61–2.97)

4.67 (4.54–4.80)

7.25 (6.71–7.45)

10.72 (10.07–11.06)

13.66 (12.76–14.11)

15.28 (14.94–15.38)

15.35 (14.60–16.75)

13.43 (12.26–14.77)

9.83 (9.63–9.92)

Cardiovascular Diseases

2.59 (2.00–2.88)

4.50 (3.79–5.11)

7.92 (6.46–8.46)

11.8 (9.74–13.57)

17.07 (12.67–19.16)

21.72 (16.46–25.31)

25.85 (19.37–32.25)

25.66 (17.14–33.87)

13.47 (10.14–15.97)

Bronchopneumopathy

4.54 (3.88–5.42)

4.92 (4.21–5.49)

5.66 (4.84–6.32)

7.19 (6.12–7.78)

8.84 (7.43–9.81)

10.09 (8.51–11.12)

11.50 (9.93–12.05)

10.58 (8.44–12.12)

7.58 (6.40–8.38)

Gastrointestinal diseases

2.38 (1.96–2.61)

2.23 (1.87–2.71)

2.07 (1.54–2.49)

2.07 (1.88–2.24)

2.25 (1.89–2.51)

2.19 (1.63–2.53)

1.83 (1.41–2.26)

1.36 (0.91–1.68)

2.08 (1.68–2.41)

Neuropathy

2.10 (1.59–2.33)

2.23 (1.87–2.64)

2.81 (2.22–3.20)

3.44 (3.01–3.67)

5.38 (4.46–5.57)

8.52 (6.83–9.18)

12.67 (10.37–13.52)

16.93 (12.81–18.65)

6.08 (4.82–6.64)

Autoimmune Diseases

2.59 (2.20–2.74)

2.88 (2.40–3.25)

3.08 (2.66–3.29)

2.95 (2.42–3.50)

2.45 (1.72–3.00)

1.85 (1.37–2.35)

1.41 (1.06–1.87)

1.04 (0.75–1.25)

2.37 (1.91–2.72)

Endocrine metabolic disorders

4.91 (4.81–5.11)

6.32 (6.03–6.48)

7.52 (7.13–7.86)

8.97 (8.32–9.29)

9.76 (8.33–10.31)

9.49 (8.19–10.67)

9.85 (7.61–10.93)

8.42 (6.23–10.48)

8.03 (7.11–8.39)

Rare Diseases

1.25 (1.03–1.44)

1.13 (0.97–1.29)

1.01 (0.95–1.2)

1.08 (0.90–1.14)

0.87 (0.66–1.09)

0.69 (0.47–0.78)

0.53 (0.46–0.57)

0.21 (0.11–0.39)

0.89 (0.74–1.04)

At least one risk factor

23.49 (21.63–24.79)

28.58 (26.83–30.12)

36.96 (35.95–37.27)

44.19 (40.76–48.43)

52.78 (46.26–57.23)

55.20 (51.49–59.56)

59.92 (51.43–64.09)

51.15 (42.24–57.15)

42.66 (38.54–44.77)

No risk factor

76.51 (75.21–78.37)

71.42 (69.88–73.17)

63.04 (63.01–64.05)

55.81 (51.57–59.24)

47.22 (42.77–53.74)

44.80 (40.44–48.51)

40.08 (35.91–48.57)

48.85 (42.85–57.76)

57.34 (55.23–61.46)

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us